D&D Pharmatech Inc. (KOSDAQ: 347850)

D&D Pharmatech Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	37,763	15,642	25,504	75,958	60,612	113,057
Cash & Short-Term Investments	37,763	15,642	25,504	75,958	60,612	113,057
Cash Growth	102.91%	-38.67%	-66.42%	25.32%	-46.39%	3328.18%
Accounts Receivable	235.9	263.95	41.84	12.46	0.93	224.67
Other Receivables	1,473	1,165	286.31	94.12	30.84	-
Receivables	1,709	1,429	328.15	106.58	31.76	224.67
Prepaid Expenses	4,626	2,356	7,330	5,507	5,734	4,047
Other Current Assets	195.09	138.64	193.46	121.45	166.43	121.07
Total Current Assets	44,293	19,565	33,355	81,692	66,544	117,450
Property, Plant & Equipment	7,651	6,422	3,024	10,966	8,147	4,471
Long-Term Investments	8,368	10,776	12,326	-	-0	0
Goodwill	10,137	9,905	9,735	34,754	31,895	34,186
Other Intangible Assets	29,973	31,615	34,246	122,689	121,775	136,474
Long-Term Accounts Receivable	3.92	179.43	6.72	7.68	-	-
Other Long-Term Assets	1,098	740.73	948.44	1,000	800.14	1,086
Total Assets	101,524	79,204	93,642	251,109	229,161	293,668
Accrued Expenses	4,922	2,080	6,803	7,647	4,871	1,229
Short-Term Debt	1,679	1,521	19,225	34,836	-	-
Current Portion of Leases	1,649	1,493	1,583	1,276	712.19	594.43
Other Current Liabilities	2,535	2,393	27,312	23,100	3,558	97,422
Total Current Liabilities	10,786	7,487	54,923	66,859	9,141	99,245
Long-Term Debt	-	-	-	-	529.51	-
Long-Term Leases	6,092	5,121	6,425	7,463	4,488	1,930
Long-Term Deferred Tax Liabilities	8,124	8,564	9,239	33,367	33,122	37,253
Other Long-Term Liabilities	1,686	2,801	4,536	5,042	312.79	0
Total Liabilities	26,832	23,986	75,123	112,781	47,854	138,682
Common Stock	5,269	4,649	4,034	4,028	4,019	1,848
Additional Paid-In Capital	335,868	297,522	268,925	268,673	266,338	48,381
Retained Earnings	-308,905	-289,676	-293,610	-157,543	-89,319	-25,913
Comprehensive Income & Other	33,664	34,154	30,091	16,951	-204.76	1,560
Total Common Equity	65,896	46,650	9,440	132,109	180,833	25,876
Minority Interest	8,796	8,568	9,079	6,219	474.03	1,086
Shareholders' Equity	74,692	55,218	18,519	138,328	181,307	154,986
Total Liabilities & Equity	101,524	79,204	93,642	251,109	229,161	293,668
Total Debt	9,421	8,134	27,233	43,575	5,730	2,525
Net Cash (Debt)	28,343	7,508	-1,729	32,383	54,881	110,532
Net Cash Growth	186.01%	-	-	-41.00%	-50.35%	3371.41%
Net Cash Per Share	2884.34	800.35	-214.55	3935.19	7513.43	33046.06
Filing Date Shares Outstanding	10.54	9.3	8.07	8.06	8.04	3.7
Total Common Shares Outstanding	10.54	9.3	8.07	8.06	8.04	3.7
Working Capital	33,508	12,078	-21,568	14,834	57,403	18,204
Book Value Per Share	6252.59	5016.66	1170.20	16397.46	22498.20	7002.56
Tangible Book Value	25,785	5,129	-34,541	-25,333	27,163	-144,785
Tangible Book Value Per Share	2446.69	551.59	-4281.72	-3144.37	3379.44	-39182.41
Machinery	3,015	3,250	3,441	3,454	1,945	1,523
Construction In Progress	200.64	1.7	-	4.78	1,019	112.76

Source: S&P Capital IQ. Standard template. Financial Sources.